Posted On: January 22, 2020 by Essentially Women in: Essential News General
In the highly regulated environment of the DME industry, it is essential that providers comply with federal anti-fraud laws, state anti-fraud laws, supplier standards, accreditation requirements, and guidance from Medicare, Medicaid and commercial insurers. Serious consequences can occur for suppliers who violate one or more of the federal anti-fraud laws.
In a recent article from Medtrade, the "Cliff Notes" version of the federal anti-fraud guidance is provided and includes information about the following:
- Stark Physician Self-Referral Statute
- Anti-Solicitation Statute
- Beneficiary Inducement Statute
- Federal Anti-Kickback Statute (“AKS”)
- Safe Harbors
- Special Fraud Alerts and Special Advisory Bulletins
- Advisory Opinions
- States
Read the full article from Medtrade here.
0 comments